Business
What Goldman Sachs is saying about the CSL (ASX:CSL) share price after its R&D update
Image source: Getty Images
Last week was a reasonably disappointing one for the CSL Limited (ASX: CSL) share price.
Despite releasing its research and development (R&D) update for 2021, the biotherapeutics company’s shares ended the period with a weekly decline of 0.5%.
What was the reaction…
Continue Reading
-
General13 hours agoChina and Philippines trade blame over latest South China Sea clash
-
General13 hours agoSmall plane crashes into San Diego neighbourhood, setting homes and vehicles on fire
-
Noosa News22 hours agoConfusion over licensing and access to hunting grounds under WA’s strict gun laws
-
General13 hours agoOf saints and sinners | The Spectator Australia